These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18954373)

  • 1. Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients.
    Hadaya K; Ferrari-Lacraz S; Giostra E; Majno P; Moll S; Rubbia-Brandt L; Marangon N; Venetz JP; Bolle JF; Mentha G; Villard J
    Transpl Int; 2009 Feb; 22(2):242-6. PubMed ID: 18954373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant.
    Barth RN; Campos L; Kukuruga DL; Drachenberg C; Philosophe B
    Clin Transplant; 2010; 24(5):685-90. PubMed ID: 19925465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C4d immunostaining in acute humoral rejection after ABO blood group-incompatible liver transplantation.
    Neuman UP; Neuhaus P
    Liver Transpl; 2006 Mar; 12(3):356-7. PubMed ID: 16498659
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns.
    Saliba F; Ichaï P; Azoulay D; Habbouchi H; Antonini T; Sebagh M; Adam R; Castaing D; Samuel D
    Ther Apher Dial; 2010 Feb; 14(1):116-23. PubMed ID: 20438529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
    Pascual MA; Crespo M; Tolkoff-Rubin N
    Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report.
    Mosconi G; Scolari MP; Feliciangeli G; Zanetti A; Zanelli P; Buscaroli A; Piccari M; Faenza S; Ercolani G; Faenza A; Pinna AD; Stefoni S
    Transplant Proc; 2006 May; 38(4):1125-6. PubMed ID: 16757284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
    Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
    Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
    Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation.
    Kato M; Morozumi K; Takeuchi O; Oikawa T; Koyama K; Usami T; Shimano Y; Ito A; Horike K; Otsuka Y; Toda S; Takeda A; Uchida K; Haba T; Kimura G
    Transplantation; 2003 Mar; 75(5):663-5. PubMed ID: 12640306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation.
    Ferrari-Lacraz S; Berney T; Morel P; Marangon N; Hadaya K; Demuylder-Mischler S; Pongratz G; Pernin N; Villard J
    Transplantation; 2008 Jul; 86(2):357-9. PubMed ID: 18645502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.